Charles Schwab’s Nutrien NTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$149M Buy
2,369,714
+152,348
+7% +$10.7M 0.02% 580
2026
Q1
$167M Buy
2,217,366
+67,882
+3% +$4.84M 0.03% 487
2025
Q4
$133M Buy
2,149,484
+39,397
+2% +$2.32M 0.02% 578
2025
Q3
$124M Sell
2,110,087
-18,233
-0.9% -$1.06M 0.02% 604
2025
Q2
$124M Buy
2,128,320
+111,116
+6% +$6.28M 0.02% 582
2025
Q1
$100M Buy
2,017,204
+130,828
+7% +$6.69M 0.02% 651
2024
Q4
$84.4M Buy
1,886,376
+144,025
+8% +$6.84M 0.02% 758
2024
Q3
$83.8M Buy
1,742,351
+157,932
+10% +$7.61M 0.02% 772
2024
Q2
$80.6M Buy
+1,584,419
New +$86.7M 0.02% 745
2024
Q1
Sell
-17,320
Closed -$976K 3505
2023
Q4
$976K Buy
+17,320
New +$979K ﹤0.01% 2844
2020
Q3
Sell
-12,249
Closed -$393K 3361
2020
Q2
$393K Buy
+12,249
New +$426K ﹤0.01% 2925

Other funds holding NTR

Charles Schwab's NTR Position: Q2 2026 in Review

Charles Schwab increased its Nutrien (NTR) stake by 6.9% in Q2 2026, buying an estimated $10.7M and bringing the position to 2,369,714 shares worth $149M. The position accounts for 0.02% of the portfolio, ranked #580.

Charles Schwab first reported a position in NTR in Q2 2020 and has held it in 11 quarters since. The position peaked at $167M in Q1 2026. 728 funds tracked by Wall St. Rank hold NTR as of Q2 2026.

  • Charles Schwab held 2,369,714 shares of Nutrien worth $149M as of Q2 2026.
  • Charles Schwab bought 152,348 Nutrien shares in Q2 2026, an estimated $10.7M.
  • Nutrien made up 0.02% of Charles Schwab's portfolio in Q2 2026, its #580 holding.
  • Charles Schwab first reported a position in Nutrien in Q2 2020 and has held it in 11 quarters since.
  • Charles Schwab's Nutrien position peaked at $167M in Q1 2026.
  • 728 funds tracked by Wall St. Rank held Nutrien as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.